4//SEC Filing
Phillips Scott B. 4
Accession 0001209191-09-021632
CIK 0001302554other
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 5:28 PM ET
Size
6.6 KB
Accession
0001209191-09-021632
Insider Transaction Report
Form 4
Phillips Scott B.
DirectorSVP, Scientific Affairs
Transactions
- Award
Common Stock Options
2009-04-07+50,000→ 50,000 totalExercise: $1.53Exp: 2019-04-07→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]Such options vest in five equal annual installments, commencing 04/07/2010.
- [F2]Reported amount excludes: (i) options to purchase 158,859 shares of the Company's common stock, initially exercisable on 05/03/2000 and expiring on 05/03/2009, at an exercise price of $0.28; (ii) options to purchase 397,148 shares of the Company's common stock, initially exercisable on 10/18/2000 and expiring on 10/18/2009, at an exercise price of $0.28; (iii) options to purchase 205,193 shares of the Company's common stock, initially exercisable on 12/10/2003 and expiring on 12/10/2012, at an exercise price of $0.33; (iv) options to purchase 231,670 shares of the Company's common stock, initially exercisable on 01/12/2005 and expiring on 01/12/2014, at an exercise price of $0.33; (v) options to purchase 661,913 shares of the Company's common stock, initially exercisable on 04/06/2006 and expiring on 04/06/2015, at an exercise price of $0.34.
Documents
Issuer
Winston Pharmaceuticals, Inc.
CIK 0001302554
Entity typeother
Related Parties
1- filerCIK 0001447383
Filing Metadata
- Form type
- 4
- Filed
- Apr 14, 8:00 PM ET
- Accepted
- Apr 15, 5:28 PM ET
- Size
- 6.6 KB